FilingReader Intelligence
Leadman Biochemistry stock jumps 35% amid acquisition plan
August 9, 2025 at 05:18 AM UTC•By FilingReader AI
Beijing Leadman Biochemistry's stock jumped 34.99% over two trading days following announcement of plans to acquire up to 70% of Beijing Saimen Xiangrui Bio-Products for cash.
The company reported 2024 revenue of 370.23 million yuan but posted a net loss of 75.10 million yuan. The acquisition remains in early stages and faces potential financing challenges.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Beijing Leadman Biochemistry publishes news
Free account required • Unsubscribe anytime